Gene Query: FYCO1

Dataset Description Geneva Score
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 46.71
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 36.81
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 32.61
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 32.46
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 32.39
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 32.01
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 30.95
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 30.95
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 30.7
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 29.36
A sister of NANOG regulates genes expressed in pre-implantation human development 26.78
Differential gene expression in Jagged1 treated human dental pulp cells. 26.39
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 25.4
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 23.84
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 23.04
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 22.67
Illumina Total RNA-seq in HeLa 22.18
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 21.52
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 21.21
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 21.21
Transcriptome analysis of U87 cells upon LINC00152 knockdown 20.99
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 20.35
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 18.89
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 18.69
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 18.5
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 18.43
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 18.15
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 18.04
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 17.85
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 17.85
RNA-seq of young and quiescent MRC-5 human fibroblasts 17.85
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 17.81
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 17.74
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 17.74
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 17.37
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 17.21
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 17.21
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 16.36
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 16.36
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 16.07
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 16.04
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 15.79
LNCaP treated with iBET 15.67
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 15.17
Effect of CHKA knockdown on C4-2 cell transcriptome 14.89
Cell responses to dysregulated VZV-induced cell-cell fusion 14.31
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 14.23
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 14.05
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 13.93
Lipid degradation promotes prostate cancer cell survival 13.58
Differential expression of genes in AD169-infected MRC5. 13.53
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 13.35
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 13.18
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 13.18
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 13.03
Chromatin-informed inference of transcriptional programs in gynecologic cancers 13.03
Inhibition of TNBC metastasis by Gpx1 12.86
RNA-sequencing of formalin fixed human primary melanoma tissue 12.83
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 12.54
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 12.52
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 12.47
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 12.18
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 12.15
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 11.94
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 11.87
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 11.65
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 11.58
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 11.58
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 11.55
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 11.55
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 11.45
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 11.44
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 11.35
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 11.33
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 11.33
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 11.23
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 11.18
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 11.12
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 11.09
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 11.03
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 11.03
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.86
Gene expression changes caused by KRAS in MCF-10A 10.69
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 10.61
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 10.59
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 10.54
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 10.35
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 10.33
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 10.32
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 10.25
A transcriptome-wide divergence in protein translation scales with LIN28B expression 10.18
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 10.06
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 10.03
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 10.02
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.98
Transcriptional responses of melanoma cells to BRAF inhibition 9.8
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 9.79
MicroRNA targetome analysis during HCMV infection 9.75
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 9.72
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 9.67
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 9.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 9.54
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 9.54
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 9.51
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 9.51
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 9.49
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 9.47
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 9.44
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 9.37
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 9.24
Gene expression changes upon drug withdrawal (Mel888 cell line) 9.24
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 9.07
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 9.06
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.02
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.99
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 8.99
LIN28A modulates splicing and gene expression programs in breast cancer cells 8.99
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 8.98
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.97
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.96
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 8.95
Effect of from Human Umbilical Vein Endothelial Cells 8.92
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 8.86
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 8.82
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 8.82
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 8.81
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.8
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 8.74
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 8.74
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 8.73
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 8.73
RNA-sequencing of human liver tissue 8.68
Identification of global regulators of T-helper cell lineage specification 8.67
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.67
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.57
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.53
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.53
Analysis of transcriptional regulation by Myt1 and Myt1l 8.48
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 8.34
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 8.31
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.3
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.27
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.27
Human HAP1 cells before and after nutrient deprivation 8.23
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.23
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 8.21
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 8.2
Toxoplasma gondii infection of human retinal pigment epithelial cells 8.17
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 8.17
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.17
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 8.15
BET bromodomain inhibition 8.15
The cohesin complex prevents Myc-induced replication stress 8.12
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.1
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 8.03
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.03
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 7.99
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.99
Identification of Nrf2 regulated genes by RNA sequencing 7.96
Nrf2 regulated genes in A549 cells 7.96
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 7.95
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 7.82
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.8
FOXD3 is a novel tumor suppressor in lung cancer 7.76
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 7.7
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 7.67
RNA-seq of stable and unstable section of human atherosclerotic plaques 7.66
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.65
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.63
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 7.5
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.49
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 7.41
RNA sequencing of mechanically strained NHEKs and control NHEKs 7.4
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 7.39
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.34
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.32
RNA-seq analysis of BAP1-depleted uveal melanoma cells 7.28
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.28
4sUDRB-seq: measuring transcription elongation and initiation genomewide 7.26
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 7.24
The evolution of N6-methyladenosine in primates 7.19
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 7.18
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 7.18
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 7.18
Aneuploidy triggers an immune response 7.09
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 7.09
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.08
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.08
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 7.04
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 7.03
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 6.94
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.92
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 6.87
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 6.85
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 6.85
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 6.84
Tyrosine Kinase Inhibitor Cardiotoxicity 6.82
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 6.82
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 6.81
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 6.8
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 6.8
X-Ray induced DNA-Hydroxymethylation changes 6.74
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 6.73
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 6.73
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 6.71
Loss of CREBBP results in gene expression repression in lymphoma cells 6.71
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.71
6.62
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 6.6
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 6.6
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 6.6
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 6.58
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 6.56
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 6.53
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 6.49
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.47
Identification of Sin3B regulated genes during quiescence 6.45
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 6.45
miR-93 Targets in Human Endothelial Cells 6.44
Overexpression and knockdown experiment for circCSNK1G3 6.41
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 6.34
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 6.34
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 6.32
RNA-seq analysis of uveal melanoma cells treated with FR900359 6.3
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.27
Transcriptome of activated human and mouse MAIT cells 6.21
Gene expression changes in human melanoma cell lines compared to primary melanocytes 6.18
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.18
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 6.14
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 6.1
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 6.1
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.09
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.09
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.09
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 6.08
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 6.08
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.05
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 6.03
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 6.03
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 6.03
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 6.02
RNA-seq of resting and activated CD4+ T cells +-JQ1 6.02
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 5.97
Androgen Receptor-regulated genes in prostate cancer cells 5.97
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 5.97
Regulation of hypoxia-inducible factor activity by ZMYND8 5.94
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 5.94
RNA Sequencing of Human iPS derived Cardiomyocytes 5.88
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.88
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.83
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.83
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 5.82
Widespread regulated alternative splicing of single codons accelerates proteome evolution 5.79
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 5.76
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 5.74
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.74
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.72
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 5.71
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 5.71
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 5.7
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 5.67
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 5.65
LncRNA expression profiling of ischemic stroke patients 5.62
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 5.56
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 5.52
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.48
RNAseq Study in CC-671 Treated Cal-51 Cells 5.42
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 5.42
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 5.42
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 5.38
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 5.38
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.35
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 5.35
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.33
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 5.32
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 5.3
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 5.3
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 5.3
circRNA profile in hypopharyngeal cancer 5.16
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 5.15
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 5.15
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 5.13
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 5.13
Changes in human endometrial gland transcriptome over the window of implantation 5.11
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.11
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.06
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 5.04
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 5.04
Identification of differentially expressed genes between senescence and senescence bypass cells 5.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 5.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 5.01
TFAP2C signalling in human fibroblasts 4.99
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 4.97
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.91
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.9
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 4.81
RNA-seq analysis upon ARID1B overexpression 4.78
The DNA methylation landscape of human melanoma 4.72
The DNA methylation landscape of human melanoma [RNA-Seq] 4.72
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.69
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.69
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.68
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.68
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.67
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.62
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 4.62
Proliferation-correlated expression 4.57
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.56
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.56
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.54
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.54
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.54
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 4.51
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 4.46
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 4.45
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.45
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 4.45
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.41
Random mono-allelic expression in MECP2-mutated cells 4.4
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 4.39
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 4.39
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 4.36
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 4.31
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.25
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 4.24
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 4.21
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 4.17
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 4.16
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 4.12
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.11
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.11
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.1
Characterization of parental and rociletinib-resistant derived H1975 cell lines 4.04
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 4.03
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 4.01
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.92
Metabolism as an early predictor of DPSCs aging 3.88
Region-specific Innate Antiviral Responses of the Human Epididymis 3.88
Gene expression changes after LOC550643 silencing 3.87
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 3.83
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.82
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.82
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 3.81
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 3.79
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.76
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 3.76
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 3.75
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 3.75
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.65
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.63
4sU-seq of HFF exposed to salt and heat stress 3.61
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 3.6
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.6
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.58
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.58
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.56
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 3.56
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 3.52
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.49
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.46
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.46
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 3.44
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.43
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 3.4
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.23
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.23
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.17
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.16
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.09
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.05
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 3.01
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 2.96
Identification of renal resident macrophages across species [C1] 2.87
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.86
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 2.79
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.74
Profiling of escape kinetics of viruses subjected to RNAi 2.7
Modeling Human Cancer-induced Cachexia (Human) 2.66
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 2.59
Aortic Valve Tissue: Stenosis vs. Sclerosis 2.58
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.52
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.51
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.51
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.46
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.39
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.39
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 2.38
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.36
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.27
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.24
Molecular analysis of renal cell carcinoma with unclassfied histology 2.24
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.23
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.2
Effects of transcription on genome - nuclear lamina interactions 2.2
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.2
Oncogenic roles of ARID5B in T-ALL 2.2
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.19
UV_24h_GRO-Seq 2.18
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.1
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.09
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 2.08
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.04
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.98
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.98
MAIT cell RNA sequencing 1.96
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.95
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.91
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 1.86
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.81
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.77
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.77
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 1.76
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.75
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.75
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 1.75
The transcriptome of Kawasaki Disease arteritis 1.75
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.75
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.72
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 1.7
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 1.7
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.64
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.55
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 1.54
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 1.48
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.47
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.47
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.45
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.44
Identification of expressed and conserved human non-coding RNAs 1.41
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.38
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.38
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.38
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.38
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.36
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.36
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.29
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.29
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.24
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.22
mRNA recovered upon RNF219 IP. [RNA-IP] 1.2
Intron retention induced by microsatellite expansions as a disease biomarker. 1.18
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.1
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.08
Dilated cardiomyopathy vs Myocarditis 1.05
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 1.0
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 0.99
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.97
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.89
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.88
RNAseq of Breast cancer PDX samples 0.88
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.87
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.87
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 0.79
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.78
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.77
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.77
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.72
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.68
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.67
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.66
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 0.61
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.6
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.57
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.54
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.54
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.54
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.48
The cytokine environment influence on human skin-derived T cells 0.46
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.38
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.34
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.34
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.32
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.32
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.29
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 0.29
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.27
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 0.25
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.23
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.23
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.23
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 0.23
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.2
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.2
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.2
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.18
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.16
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.13
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 0.13
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.11
Gene expression profiling of KSHV-infected periodontal ligament cells 0.1
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.09
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.07
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.06
Preclinical model of obesity and ER-positive breast cancer 0.05
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.04
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.03
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.02
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.01
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation